morn report result expect sale ep highlight
quarter neotract nt sale organ growth guidanc
move higher previous view achiev given
signific runway ahead neotract core improv specifc nt
guidanc remain conserv view given y/i growth first half
impli deceler despit reimburs tailwind urolift launch
consequ reiter overweight rate
morn report sale cc basi
nice street estim urolift came ahead model
post growth y/i gm bp y/i
om later larg due fx fx-neutral basi om would
flat y/i adj ep beat consensu cent
revenu guidanc higher ep re-affirmed put take
increas cc revenu growth guidanc rang
line manag re-affirmed gross margin lower op margin
given currenc increas spend urolift japan
dtc manta lower tax rate interest expens adjust ep remain
point call sever key takeaway call earlier today first
manag take outlook rest increas organ
outlook well expect even believ neotract
growth project increas bp remain conserv given y/
growth first half impli deceler despit reimburs
tailwind urolift launch next import piec news view
pushback repla refer ez-plaz go forward bla submiss
expect year submiss ez-plaz take time
expect fda uniqu biolog manag view
temporari setback addit remind investor meaning revenu
bake lrp product manag talk
stock share given strong print even
strong move name year think room out-performance given
still conserv neotract project core improv along manag
prove leverag stori reiter ow rate
failur realiz margin expans product recal competit
global diversifi medic technolog product provid
ep estim
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
price increas price target base
given out-performance increas outlook busi core improv also
updat ep estim
sourc compani report piper jaffray co estim
page
good expens net incom analysi gross analysi vascular inc
thousand except per share data
good sold
good sold
percent sale
good sold
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
